CASE Member - Elected 2015
John Kadow is a medicinal chemist with considerable experience as a drug hunter in the pharmaceutical industry. Most recently he served as Senior Director of Medicinal Chemistry at ViiV Healthcare where he led a team of medicinal chemists who helped produce drug candidates aimed at improving the lives of people living with HIV. Prior to that, he worked at Bristol-Myers Squibb Co. where he reached the position of Group Director of Medicinal Chemistry and co-led teams in the virology and oncology therapeutic areas which progressed more than ten compounds to the development organization including two that realized approvals. John was a member of a BMS Team who received a PhRMA 2014 Research & Hope Award for Excellence in Biopharmaceutical Research for the discovery and early development of an HIV attachment inhibitor.
He became a member of the Connecticut Academy of Science and Engineering (CASE) in 2015 and is currently serving a two-year term as president that began in July of 2022. John is a co-inventor on more than 135 patent applications and a co-author on many peer-reviewed publications. Prior to joining the pharmaceutical industry, John did postdoctoral research in synthetic chemistry at Yale University in New Haven, CT. John received his PhD in Synthetic Organic Chemistry from Wayne State University in Detroit, MI, and a BA in chemistry from Hope College in Holland, MI.